Autoinjectors To 2018 - Devices, Therapeutics, Markets, Strategies And Prospects
NEW YORK, March 4, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Autoinjectors to 2018 - Devices, Therapeutics, Markets, Strategies and Prospects
http://www.reportlinker.com/p0850146/Autoinjectors-to-2018---Devices-Therapeutics-Markets-Strategies-and-Prospects.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Until recently, autoinjectors were designed to be reused. The reason was that the injectors were too expensive to be successfully marketed as a throw-away device. Recent improvements in materials technology and device design have led to the creation of a class of autoinjectors that can be made economically in high production quantities, opening the door for the disposable autoinjector, and providing expanded opportunities for both patient and drug marketer.
Highlights • Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments • Analyzes design factors, material selection issues, technologies and market development issues • Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations • Charts market data and forecasts to 2018 Table of Contents Executive Summary Injectable Drug Delivery Market Dynamics The Economics of Injectable Drugs What's Driving the Growth in Autoinjectors? Prefilled Syringes Proliferating The Trend toward Self-Administration Shifting Demographics Innovation in Disposable Device Designs Therapeutic Demand Drivers Competitive Landscape Risk Factors Autoinjectors – Commercial Devices Manual injection Autoinjectors Automated Injection Autoinjectors Reusable Autoinjectors Disposable Autoinjectors Bundled (Pre-assembled) Autoinjectors Product Specific Autoinjectors Autoinjector Device Design Factors Material Selection Issues Part Counts and Device Cost Safety Features Needle Shielding Needle Insertion Depth Failsafe Activation Dose Inspection/Injection Confirmation Lyophilized Drugs/Reconstitution Human Engineering/Ergonomics Autoinjector Drug Delivery – Key Therapeutic Sector AnalysisSelect the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
